A detailed history of Brevan Howard Capital Management LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 13,479 shares of ACAD stock, worth $230,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,479
Previous 33,336 59.57%
Holding current value
$230,086
Previous $541,000 61.74%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.14 - $19.14 $300,634 - $380,062
-19,857 Reduced 59.57%
13,479 $207,000
Q2 2024

Aug 14, 2024

SELL
$14.62 - $18.42 $7,500 - $9,449
-513 Reduced 1.52%
33,336 $541,000
Q1 2024

May 15, 2024

BUY
$17.79 - $30.86 $285,333 - $494,963
16,039 Added 90.06%
33,849 $625,000
Q4 2023

Feb 14, 2024

BUY
$20.78 - $31.77 $370,091 - $565,823
17,810 New
17,810 $557,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.